RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:I am getting enviousAlso, why isn't Grinspoon listed as a Scientific consultant when the oncologists are? I get that the platform may ba a huge value driver down the road, but what about the man that got the company here? Heads ought to Rolle for that.
SABBOBCAT wrote: It is ridiculous. If management gets paid for his work it would be a huge mistake. The BOD needs to recognize and acknowledge that. Give Grinspoon the options that management has come to expect regardless of performance. Grinspoon is the only reason there is a bright spot on the horizon following the trogarzo sales disappointment. Luc got his options for saving the company. He should not be entitled to more of them for lackluster performance. Give credit where it's due!
palinc2000 wrote: Sabbocoat
I was flabbergasted when I found out that TH did not even supply Egrifta free of charge,,,,,and when Grinspoon mentioned in his report that apart from supplyng Egrifta at a reduced price TH had NO input whatsoever during the trial
I still have a bad feeling about Grinspoon not being physically present at the R&D Day and moreover that he had to step away from the teleconference early
This does not indicate imo a very friendly relation....However I have no direct knowledge